“…Besides, a PS in long-lived T 1 state can also participate in the formation of superoxide (O 2 • – ) or hydroperoxyl radicals (HO 2 • ) through transferring electrons to cellular substrates through a type I reaction. − Different kinds of ROS and radicals generated by those two types of photochemical reactions can kill cancer cells in a PDT therapeutic manner. − Selective and efficient PDT can also be realized by precisely manipulating the light irradiation area, which is an effective way to minimize side effects to healthy tissues . Besides, PDT exhibits several other merits such as noninvasiveness, few side effects, negligible drug resistance and low systemic toxicity, all of which has motivated scientists to work on PDT as a therapeutic modality for disease treatment. , As one of the key elements in PDT, various PSs such as porphyrin, chlorin, phthalocyanine, squaraine, BODIPY derivatives, and transition metal complexes have been explored so far to date. − The development of PSs with a superior organelle targeting capability can help to realize precision PDT toward cancer treatment. , However, most of the existing PSs are still far from the ideal, they should possess characteristics including strong absorption at long wavelengths, efficient photosensitization, negligible dark toxicity, and good photostability and biocompatibility. , In addition, these conventional PSs often possess a rigid planar π-conjugated structure and are prone to aggregate in aqueous media, resulting in significantly decreased photosensitization behavior and emission, which is another critical obstacle for conventional PSs in PDT applications. , In this regard, the discovery and development of PSs with AIE characteristics presents a promising alternative approach. − Herein, the application of AIE PSs in organelle targeted PDT and PDT-induced treatment will be discussed.…”